SEC Form 4 · accession 0001214659-26-007398
Aquestive Therapeutics, Inc. · AQST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Krop
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 11:43 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001398733
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $3.99 | Jun 10, 2026 | A | 50,500 | A | Jun 10, 2027 | Jun 10, 2036 | Common Stock | 50,500 | 50,500 | D |
Explanation of responses
- F1The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.